For anyone interested in investing in the health-care space, JPMorgan's annual Health Care Conference has become one of the most important events of the year. We were not able to get to San Francisco this year, but one of our favorite Odd Lots guests, James van Geelen of CitriniResearch.com, was in attendance. He called into this week's episode of Lots More to tell us what the leading players in health care and medical technology are buzzing about right now — and he confirms that AI and GLP-1 weight loss drugs are at the top of everyone's mind."
See omnystudio.com/listener for privacy information.
Lots More With Luke Kawa on Memestock Mania 2.0
How a DOJ Economist Approaches Antitrust in America
Introducing: Big Take Asia
How to Succeed at Multi-Strategy Hedge Funds
Jeff Currie on Why Copper Is His Highest-Conviction Trade Ever
Pierre Andurand Says the World Could Run Out of Cocoa Inventories
Viktor Shvets on How the Fed Has Become a Prisoner of Its Own Making
Lots More With Brad Setser on the Yen, a New China Shock and Excavators
Hugh Hendry on the "Terrifying" Yen Move, and Risk of "Mad Max" Deflation
What a Fed President Hears When He Goes on the Road
Lots More on How CHIPS Act Money Got Awarded
Luis von Ahn Explains How Computers and Humans Learn From Each Other
The Ultra Wealthy Have Their Own Separate World of Real Estate
An Ex-CIA Officer Explains How to Spot a Lie in Business
Here's Who's Winning the Global Fight for AI Talent
Josh Wolfe: The ChatGPT of Robotics is Coming
Richmond Fed President Tom Barkin On Getting Inflation Under Control
What AMLO's Legacy Means For Mexico's Upcoming Election
How The American Workforce Got Hooked on Adderall
How Electric Utilities Will Handle Booming AI Datacenter Demand
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
TED Radio Hour
FT Alphachat
Freakonomics Radio
Goldman Sachs Exchanges
Slate Money